Financials

News Ideas Technicals

WNT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

WntResearch AB engages in the research and development of novel anti-metastatic therapies for the treatment of cancer patients. Its products include Foxy-5 and Box-5. The company was founded by Tommy Evert Andersson, Bert Roland Kari Junno, and Sten Trolle on September 24, 2007 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

WNT does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company